Mediwound Ltd (MDWD)
Healthcare
Biotechnology
14.20 $
+0.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Mediwound Ltd (MDWD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 69.3% of the shares are freely tradable; institutional investors hold 58.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
58.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
15.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
69.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
15.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
13Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Investors Finance Co PLC | 6.79 | 872,093 | +0.0 | 03/31/2026 |
| Yelin Lapidot Holdings Management Ltd | 5.94 | 762,817 | +0.0 | 03/31/2026 |
| Rosalind Advisors, Inc. | 5.83 | 749,054 | +0.0 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 5.52 | 709,847 | +28.0 | 03/31/2026 |
| BlackRock Inc | 3.47 | 445,834 | -2.2 | 03/31/2026 |
| Meitav Dash Investments Ltd | 2.89 | 371,868 | +0.1 | 03/31/2026 |
| Sphera Funds Management Ltd. | 2.13 | 273,192 | +18.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 1.92 | 246,280 | +2.0 | 03/31/2026 |
| T. Rowe Price New Horizons | 1.92 | 246,170 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 1.61 | 207,149 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.